SICKLING DISORDER DUE TO HEMOGLOBIN S

Clinical trials for SICKLING DISORDER DUE TO HEMOGLOBIN S explained in plain language.

Never miss a new study

Get alerted when new SICKLING DISORDER DUE TO HEMOGLOBIN S trials appear

Sign up with your email to follow new studies for SICKLING DISORDER DUE TO HEMOGLOBIN S, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

New radioactive antibody could make sickle cell transplants safer

Disease control Recruiting now

This early-phase study is testing a new drug called 131I-apamistamab, which combines an antibody with radioactive iodine, to prepare people with severe sickle cell disease for a bone marrow transplant. The goal is to find the smallest effective dose that allows the donor stem cel…

Matched conditions: SICKLING DISORDER DUE TO HEMOGLOBIN S

Phase: PHASE1 • Sponsor: Columbia University • Aim: Disease control

Last updated Jun 27, 2026 13:07 UTC

SICKLING DISORDER DUE TO HEMOGLOBIN S

Get alerted when new SICKLING DISORDER DUE TO HEMOGLOBIN S trials appear

New radioactive antibody could make sickle cell transplants safer